Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | F7 | P08709 | 1/20 | 0.36 |
| ▸ | F3 | P13726 | 1/20 | 0.36 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.36 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.36 |
| ▸ | CDK8 | P49336 | 10/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.33 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | PAK4 | O96013 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623343 | 1.00 | SIRT3 (0.38) | SIRT3TDP1F7F3SARM1 | |
| SCHEMBL30539758 | 0.87 | SIRT3 (0.38) | SIRT3TDP1F7F3SARM1 | |
| SCHEMBL8366169 | 0.85 | KDM4C (0.36) | TDP1TSHRKDM4EMKNK1MKNK2 | |
| SCHEMBL30440354 | 0.85 | KDM4C (0.36) | TDP1TSHRKDM4EMKNK1MKNK2 | |
| SCHEMBL35211554 | 0.80 | — | — | |
| SCHEMBL715561 | 0.78 | HSD17B10 (0.33) | TDP1AURKATSHRKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL6204990 | 0.77 | HSD17B3 (0.33) | TDP1AURKATSHRMAPTL3MBTL1 | |
| SCHEMBL2877013 | 0.74 | PRKCI (0.40) | CDK8CHEK1DAPK3PRKD3MAP4K4 | |
| SCHEMBL30818429 | 0.73 | SIRT3 (0.40) | SIRT3TDP1F7F3SARM1 | |
| SCHEMBL27791683 | 0.72 | KDM4C (0.37) | TDP1KDM4EMEN1KDM6BKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023056951-A1 | ARYL-SUBSTITUTED HETEROCYCLIC COMPOUND | 杭州德睿智药科技有限公司 | 2023-04-13 | — | — | WO | disclosed |
| CN-108137587-B | Method for preparing and recovering amide compound | 拜耳制药股份公司 | 2020-10-23 | — | — | CN | disclosed |
| CN-110511219-A | The dihydronaphthridine class compound and application thereof that phenyl replaces | GUANGDONG HEC PHARMACEUTICAL | 2019-11-29 | — | — | CN | disclosed |
| CN-110022871-A | Combination comprising sGC stimulators and mineralocorticoid receptor antagonists | 拜耳制药股份公司 | 2019-07-16 | — | — | CN | disclosed |
| CN-109890379-A | Combination comprising an sGC activator and a mineralocorticoid receptor antagonist | 拜耳制药股份公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-108473488-A | The preparation method and its usage of the metabolin of (4S)-and (4R) -4- (4- cyano -2- methoxyphenyls) -5- ethyoxyl -2,8- dimethyl -1,4- dihydro -1,6- naphthyridines -3- formamides | 拜耳制药股份公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108137587-A | Method for producing (4S) -4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyridine-3-carboxamide by means of electrochemical methods and for recovering (4S) -4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyridine-3-carboxamide | 拜耳制药股份公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-107849043-A | For preparing the method for the formamide of 1,6 naphthyridines of (4S) 4 (methoxyphenyl of 4 cyano group 2) 5 ethyoxyl, 2,8 dimethyl, 1,4 dihydro 3 and its for the purifying as pharmaceutically active substance | 拜耳制药股份公司 | 2018-03-27 | — | — | CN | disclosed |
| EP-2201010-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009036412-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-03-19 | — | — | WO | disclosed |